Lv1
98 积分 2022-05-24 加入
Talquetamab–Daratumumab in Relapsed or Refractory Myeloma
9小时前
待确认
Diagnostic Challenges of Acute Kidney Injury in a Patient With High-Risk Multiple Myeloma: A Quiz
9天前
已关闭
Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps Conference
9天前
已完结
Advancements in bispecific antibodies for multiple myeloma: What's new and what lies ahead
1个月前
已完结
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial
1个月前
已完结
Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment
1个月前
已完结
Treatment of Refractory Monoclonal Immunoglobulin Deposition Disease With BCMA Bispecific Antibody
1个月前
已完结
Monoclonal Immunoglobulin Deposition Disease - a Review of Current and Emerging Data
1个月前
已关闭
An otherwise smouldering multiple myeloma with a solitary osteolytic lesion and soft-tissue mass
2个月前
已关闭
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing
5个月前
已完结
皖公网安备34019202002308
